Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRQIH.L Regulatory News (RQIH)

  • There is currently no data for RQIH

Loss Portfolio Transfer

8 Sep 2021 07:00

RNS Number : 9906K
Randall & Quilter Inv Hldgs Ltd
08 September 2021
 

 

 

Randall & Quilter Investment Holdings Ltd.

 

Loss Portfolio Transfer & Reinsurance Business Transfer with Delvag Versicherungs-AG

 

8 September 2021

 

Randall & Quilter Investment Holdings Ltd. (AIM-RQIH) ("R&Q"), the leading non-life global specialty insurance company focusing on Program Management and Legacy Insurance businesses, is pleased to announce that with the close assistance of Black Forest Reinsurance Consulting ("BFRC") and the broker and sell-side advisor, Guy Carpenter & Company GmbH, Munich, it has transacted a Loss Portfolio Transfer of reinsurance business with Delvag Versicherungs-AG, Germany ("Delvag") an insurance captive fully owned by Lufthansa Group.

 

The reinsurance is being provided by R&Q's A.M. Best A- (Excellent) rated carrier in Malta, Accredited Insurance (Europe) Limited ("Accredited").

 

With this transaction Delvag reaches economic finality of a third-party reinsurance portfolio amounting to circa EUR 22million of reserves that has no active client relationships and that was underwritten from 1969 onwards. Further, this transaction also encompasses the mutual interest to undertake an Insurance Business Transfer of the portfolio to Accredited, subject to regulatory approvals.

Paul Corver, Group Head of M&A at R&Q explained: "We are delighted to have completed another Loss Portfolio Transfer with the mutual intention to follow on with a Reinsurance Business Transfer from Germany to Malta. We have assumed numerous portfolios of business from across Europe into our rated Maltese platform which provides complete finality to the cedant along with the accompanying cost and capital efficiencies. We are very pleased to have executed this transaction with Delvag. Once again it proves R&Q's capabilities to utilize its international team to provide full finality legacy solutions across the US and Europe and here in particular in the DACH region. We look forward to working closely with BFRC to conclude further legacy deals in the near future."

 

Andreas Brügel, Director Reinsurance at Delvag explained: "After Delvag's decision to cease writing third-party reinsurance business after 50 years this portfolio transfer was the logical consequence to free-up Solvency II capital. This fundamentally supports the reinsurance department's new strategy to concentrate on providing services as a Group captive instead of primarily acting as a third-party business writer. The strategic alignment of Delvag's Aviation and Marine department remains unaffected by this transaction"

 

Ends

 

Enquiries to:

 

Randall & Quilter Investment Holdings Ltd.

www.rqih.com

Paul Corver

Tel: 020 7780 5944

 

Numis Securities Limited (Nominated Advisor)

Stuart Skinner

Tel: 020 7260 1000

Charles Farquhar

Tel: 020 7260 1000

 

 

Barclays Bank PLC (Joint Broker)

Mark Astaire

Milan Solanki

 

Tel: 020 7632 2322

Tel: 020 7632 2322

FTI Consulting

Edward Berry/Tom Blackwell

 

Tel: 020 3727 1046

 

 

Notes to Editors:

 

 

About R&Q

 

 

R&Q is a non-life global specialty insurance company operating two core, highly complementary, businesses: Program Management and Legacy Insurance. Both these businesses are leaders in markets with high barriers to entry and significant secular growth opportunities. Legacy Insurance generates profits and capital extractions from expert management of legacy non-life insurance portfolios. Program Management generates commission income from its licensed (and rated) carriers in the US, EU and the UK, writing niche and profitable program business, largely on behalf of highly rated reinsurers.

 

Legal Entity Identifier (LEI): 2138006K1U38QCGLFC94

 

Website: www.rqih.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRASSASUWEFSEIU
Date   Source Headline
29th Jul 20247:00 amRNSCancellation - R&Q INSURANCE HOLDINGS LTD
28th Jun 20246:07 pmRNSSale of Accredited to Onex Partners
27th Jun 20247:00 amRNSAppointment of Joint Provisional Liquidators
24th Jun 20247:00 amRNSUpdate
24th Jun 20247:00 amRNSR&Q agrees sale of Inceptum
20th Jun 20244:59 pmRNSTR-1: Notification of major holdings
20th Jun 20241:12 pmRNSTR-1: Notification of major holdings
19th Jun 20242:46 pmRNSTR-1: Notification of major holdings
19th Jun 20242:26 pmRNSTR-1: Notification of major holdings
19th Jun 20247:30 amRNSSuspension - R&Q Insurance Holdings Ltd
19th Jun 20247:00 amRNSUpdate
18th Jun 20242:19 pmRNSNotification of major holdings
17th Jun 20241:29 pmRNSTR-1: Notification of major holdings
14th Jun 20243:16 pmRNSTR-1: Notification of major holdings
13th Jun 20247:35 amRNSUpdate on proposed sale of Accredited
24th Apr 20245:40 pmRNSUpdate on proposed sale of Accredited
19th Apr 20247:00 amRNSAppointment of Non-Executive Directors
12th Apr 20247:00 amRNSUpdate on Trading and Sale of Accredited
12th Mar 20242:33 pmRNSTR-1: Notification of major holdings
1st Mar 20247:00 amRNSComment on recent press speculation
11th Jan 20244:01 pmRNSShareholders approve sale of Accredited
4th Jan 20244:27 pmRNSIncrease in the number of Treasury Shares
2nd Jan 20247:00 amRNSRetirement of Alan Quilter
22nd Dec 20237:00 amRNSUpdate on discussions with the BMA
21st Dec 202311:12 amRNSTR-1: Notification of major holdings
14th Dec 20237:00 amRNSPosting of Circular
16th Nov 20239:58 amRNSTR-1: Notification of major holdings
14th Nov 20237:00 amRNSUpdate on Proposed Sale of Accredited
27th Oct 20234:52 pmRNSPDMR/Director Shareholding and Total Voting Rights
26th Oct 20237:00 amRNSLoss Portfolio Transfer
26th Oct 20237:00 amRNSChange of External Auditor
20th Oct 20235:23 pmRNSProposed Sale of R&Q’s Program Management business
16th Oct 202310:59 amRNSTR-1: Notification of major holdings
29th Sep 20237:00 amRNSResults for the half year ended 30 June 2023
22nd Sep 20237:00 amRNSStatement re Press Comment
20th Sep 202311:55 amRNSTR-1: Notification of major holdings
20th Sep 202311:54 amRNSTR-1: Notification of major holdings
16th Aug 20233:36 pmRNSPDMR/Director Shareholding and Total Voting Rights
28th Jul 20233:18 pmRNSResult of Annual General Meeting
18th Jul 20233:22 pmRNSTR-1: Notification of major holdings
17th Jul 20237:00 amRNSAppointment of Non-Executive Director
30th Jun 202310:08 amRNSAppointment of Non-Executive Director
30th Jun 20237:00 amRNSPosting of Annual Report and Notice of AGM
29th Jun 20237:00 amRNSResults for the year ended 31 December 2022
26th Jun 20237:00 amRNSAccredited receives independent AM Best Rating
12th Jun 20237:00 amRNSR&Q raises up to $60 million of new equity
6th Jun 20235:31 pmRNSTR-1: Notification of major holdings
5th Jun 202311:23 amRNSTR-1: Notification of major holdings
2nd Jun 20233:50 pmRNSTR-1: Notification of major holdings
16th May 20239:27 amRNSTR-1: Notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.